Full-Time
Director, Implementation Services
Posted on 8/21/2026
Faro Health
51-200 employees
Clinical trial design and collaboration platform
Compensation Overview
$200k - $225k/yr
Massachusetts, USA
Remote
Remote within the United States; candidates should be based on the U.S. East Coast and travel up to 30%.
 DevOps & Infrastructure (1) |
|---|
Get referred to Faro Health
See people who can refer or advise you
- At least 8 years of experience in Professional Services, Solutions Architecture, Technical Implementation, Integration Services, or a similar customer-facing technical SaaS role.
- Strong hands-on experience with enterprise SaaS infrastructure, including single sign-on, Security Assertion Markup Language, identity providers, application programming interfaces, authentication, service accounts, and customer system integrations.
- Experience configuring and troubleshooting structured data mappings using JavaScript Object Notation or similar formats, with a strong understanding of how data moves between systems.
- Experience developing or iterating artificial intelligence prompts or rules-based logic for data ingestion, content transformation, or workflow automation.
- Ability to work directly with customer information technology and technical teams while translating technical concepts for non-technical stakeholders.
- Strong problem-solving ability across infrastructure, integrations, data, and application configuration while building scalable processes.
- Based on the U.S. East Coast, with preference for candidates in Massachusetts, Connecticut, New York, Pennsylvania, or North Carolina, and able to travel up to 30%.
- Lead end-to-end technical implementation of Faro across customer environments, translating requirements into secure, scalable configurations, integrations, and workflows.
- Own infrastructure setup with customer information technology and Faro DevOps, including environments, single sign-on and Security Assertion Markup Language configuration, identity provider configuration, user access, service accounts, application programming interfaces, and other technical prerequisites for go-live.
- Scope, coordinate, and troubleshoot application programming interface integrations and system connections across customer information technology, DevOps, Product, and Engineering to resolve issues and keep implementations moving.
- Define, configure, validate, and troubleshoot JavaScript Object Notation-based field mappings connecting customer and third-party data to Faro’s structured data model and downstream systems.
- Develop, test, and refine custom artificial intelligence prompts supporting customer-specific data ingestion and protocol authoring workflows, including extracting, classifying, transforming, and structuring clinical content.
- Translate customer requirements into practical technical solutions, including configuration changes, scripts, workflow adaptations, data transformations, and third-party connections.
- Build repeatable implementation playbooks, standards, and processes that improve consistency and time-to-value as Faro scales.
- Manage a Project Manager responsible for implementation timelines and deliverables, and partner with Customer Strategy, Solutions Onboarding, Product Experience, Product, DevOps, and Engineering.
- Experience in life sciences, clinical development, or another regulated enterprise software environment.
- Familiarity with clinical data, structured data standards, or protocol design workflows.
- Experience building or scaling an Implementation, Professional Services, or Technical Services function and/or deeper experience with generative artificial intelligence workflows.
Faro Health provides a software platform that helps research teams design and run clinical trials more efficiently. It offers a single, flexible surface where users can manage data, documents, words, and team collaboration, consolidating protocols, spreadsheets, and workflow apps in one place. The platform works by centralizing all components needed for protocol design and trial execution, enabling teams to design, review, and implement trials with less back-and-forth and faster decision-making. Faro Health differentiates itself by offering an integrated, end-to-end environment focused on reducing operational cycle time and improving trial quality through centralized data and workflows, rather than scattering resources across separate tools. The company’s goal is to help research teams design and implement clinical trials more efficiently and effectively, shortening timelines and streamlining processes through a subscription-based software solution.
Company Size
51-200
Company Stage
Early VC
Total Funding
$35M
Headquarters
San Diego, California
Founded
2019
Get referred to Faro Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 2026 Fierce AI finalist status keeps Faro visible in biopharma procurement.
- January 2026 CDISC win strengthens credibility with standards-heavy clinical operations teams.
- April 2025 ISO 27001 certification reduces enterprise security objections during 2026 sales cycles.
What critics are saying
- Faro still sells workflow software; Veeva and Medidata can bundle similar features faster.
- Bristol Myers Squibb and Merck pilots do not guarantee recurring, company-wide contracts by 2027.
- If AI protocol drafting commoditizes, Faro becomes a niche feature inside larger platforms.
What makes Faro Health unique
- Faro's AI protocol design platform won TransCelerate's 2026 Protocol Review Challenge.
- April 2026 Bristol Myers Squibb collaboration validates enterprise-grade clinical development workflows.
- Merck-linked 2024 study quantified protocol savings using Faro's Study Designer tool.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Unlimited Paid Time Off
Paid Sick Leave
Paid Holidays
Training Programs
Hybrid Work Options
401(k) Retirement Plan
Stock Options
Company Social Events
Growth & Insights and Company News
6 month growth
↓ -3%1 year growth
↓ -5%2 year growth
↓ -3%Vivian joins Faro Health Inc. as the company aims to accelerate the growth and adoption of its market-leading SaaS platform for data-driven clinical development.SAN DIEGO, CA / ACCESSWIRE / June 17, 2024 / Faro Health Inc., the leading SaaS platform for data-driven clinical development, is pleased to announce the appointment of Vivian DeWoskin as Chief Strategy Officer.Vivian joins the Faro Health team as the company looks to significantly accelerate the market footprint for its AI-based platform, which aims to transform the clinical trial protocol development process by enabling data-driven, patient-focused decisions in protocol development. Vivian brings a unique combination of skills and experience gained across roles in consulting, sales, product strategy, and commercial leadership that will be essential in defining and solidifying Faro's leadership position in the market.Vivian's passion for the intersection of AI and healthcare began in her undergraduate education at Princeton University, where she studied cognitive and computational neuroscience and developed a deep appreciation for data and predictive modeling. She spent the early years of her career deeply immersed in all stages of drug development and commercialization at Trinity Life Sciences, gaining first-hand experience in the challenges of bringing new therapeutic innovations to market in an efficient and competitive manner. After pursuing her MBA at Berkeley-Haas, Vivian joined Komodo Health in 2019, where she would eventually serve as VP and Head of Strategy, situated at the intersection of commercial leadership and market strategy, as Komodo scaled their data and analytics software business to hundreds of life sciences customers. Most recently, Vivian returned to her neuroscience roots and deepened her passion for supporting Clinical Development as Chief Commercial Officer of NeuraLight, a digital biomarker company focused on neurodegenerative disease
Faro Health Inc. appoints Vivian DeWoskin as Chief Strategy Officer.
Digital tool gives real-time feedback on the impact of changes to clinical study protocols, helping clinical teams reduce the cost, duration and burden of studies on sponsors, sites and patients.SAN DIEGO, CA / ACCESSWIRE / May 29, 2024 / A new study, published in the peer-reviewed journal Therapeutic Innovation & Regulatory Science and conducted in collaboration with Merck, shows that when Faro's Study Designer Tool was applied to clinical trial protocol development using a lean design methodology, it was easy to visualize, quantify, and therefore recommend, trial improvements.Specifically, the Faro Study Designer Tool compared a lean design approach, which starts from a "ground zero" schedule of assessments before adding changes, to the traditional, copy-and-paste method, which uses a past, complete schedule of assessments. In doing so the Tool showed that for certain trials, when using a lean design methodology, there would be less burden to study participants, trial sites and staff, a reduction in overall costs, and a shorter trial."The biggest problem in clinical protocol development today is that protocols are designed in Microsoft Word. No real-time feedback is given to clinical teams, making it harder to assess the impact of complex decisions that affect everyone involved, from patients to site staff, caregivers, regulators, and payers," said Scott Chetham, CEO, Faro Health. "This study demonstrates that when immediate, measurable feedback is generated by a patient-centric, digital tool, it can reduce the cost, time and burden of conducting clinical studies. This empowers clinical teams to focus on what matters and make smart, strategic decisions to improve their trial design and the overall experience for patients."The study, "A Method to Redesign and Simplify Schedules of Assessment and Quantify the Impacts," addresses the growing complexity of pharmaceutical-sponsored clinical trials and the adverse impacts on participants, sites and sponsors, including difficulty recruiting and retaining patients and engaging sites to conduct trials, rising costs, and increased trial durations. The study focused on improving the schedule of assessments (SoA), considered the blueprint for trial protocols that is more often generated by copy and pasting from previous SoAs.The lean design approach approach, which starts with a "ground zero" SoA, was used by teams at Merck across six clinical trials
Digital tool gives real-time feedback on the impact of changes to clinical study protocols, helping clinical teams reduce the cost, duration and burden of studies on sponsors, sites and patients
SAN DIEGO, CA / ACCESSWIRE / March 25, 2024 / Faro Health Inc., the emerging leader in clinical trial development using AI to optimize protocol design and outcomes, is pleased to announce the appointment of Patrick Leung as Chief Technology Officer.This appointment comes at a time of significant momentum for Faro Health as it continues to evolve its AI-based platform for optimal clinical trial design and document generation. Patrick is a native of New Zealand with degrees in Computer Science and Finance. Early in his career, he was a founding employee at one of the first e-commerce software vendors where he helped lead the company from pre-seed stage to IPO.Later in his career, Patrick spent over a decade at Google leading Engineering teams in many groups, culminating in the launch of Google Duplex - a then-state-of-the-art AI system for conducting natural conversations to carry out real-world tasks over the phone. After Google, Patrick became CTO of Two Sigma Investments, one of the world's leading algorithmic hedge funds, where he pioneered the application of AI and alternative data to the private equity markets. Patrick's leadership in the development of such major advances in the application of AI to real-world problems makes him the ideal choice to lead Faro Health's technology and product efforts. In 2020, Patrick's passion for service led him to co-found Earthshot Labs, an NSF-funded AI platform for tropical reforestation and conservation